Daniel Oliver
Tracked across 1 events · 6 articles · First seen Jun 08, 2026 · Last active Jun 11, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Rejuvenate Bio>>>, a biotechnology company specializing in gene therapies for chronic and age-related diseases, has successfully closed a $6 million financing round. The round was led by VCapital>>> with significant participation from Ceva Santé Animale>>>,…
Impact: Daniel Oliver>>>, CEO and Co-Founder of Rejuvenate Bio>>>, expressed excitement about the financing and collaboration, highlighting the potential of gene therapy.
Jun 08, 2026 · 6 articles
NEWSDESK
Track Daniel Oliver live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard